Butyrate and Palmitoylethanolamide: Exploring Their Metabolic Potential in Explaining Clinical Improvement in Irritable Bowel Syndrome Patients, Data from A Randomised, Placebo-controlled Trial

Clinical Nutrition · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles